These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 14609670)

  • 21. Altering the drug release profiles of double-layered ternary-phase microparticles.
    Lee WL; Loei C; Widjaja E; Loo SC
    J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technique paper for wet-spinning poly(L-lactic acid) and poly(DL-lactide-co-glycolide) monofilament fibers.
    Nelson KD; Romero A; Waggoner P; Crow B; Borneman A; Smith GM
    Tissue Eng; 2003 Dec; 9(6):1323-30. PubMed ID: 14670119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
    Wang SH; Liang ZH; Zeng S
    Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
    Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
    J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
    Wang G; Tucker IG; Roberts MS; Hirst LW
    Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of load and temperature on in vitro degradation of poly(glycolide-co-L-lactide) multifilament braids.
    Deng M; Zhou J; Chen G; Burkley D; Xu Y; Jamiolkowski D; Barbolt T
    Biomaterials; 2005 Jul; 26(20):4327-36. PubMed ID: 15683657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
    Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A
    J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the in vitro cytotoxicity and modulation of the inflammatory response by the bioresorbable polymers poly(D,L-lactide-co-glycolide) and poly(L-lactide-co-glycolide).
    Geddes L; Themistou E; Burrows JF; Buchanan FJ; Carson L
    Acta Biomater; 2021 Oct; 134():261-275. PubMed ID: 34329786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo degradation of poly(L: -lactide-co-glycolide) films and scaffolds.
    Pamula E; Menaszek E
    J Mater Sci Mater Med; 2008 May; 19(5):2063-70. PubMed ID: 17968505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards developing surface eroding poly(alpha-hydroxy acids).
    Xu XJ; Sy JC; Prasad Shastri V
    Biomaterials; 2006 May; 27(15):3021-30. PubMed ID: 16455136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J; Wang BM; Schwendeman SP
    Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of electron-beam radiation on the hydrolytic degradation behaviour of poly(lactide-co-glycolide) (PLGA).
    Loo SC; Ooi CP; Boey YC
    Biomaterials; 2005 Jun; 26(18):3809-17. PubMed ID: 15626429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
    Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
    J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure formation in injectable poly(lactide-co-glycolide) depots.
    Wang L; Kleiner L; Venkatraman S
    J Control Release; 2003 Jul; 90(3):345-54. PubMed ID: 12880701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced antitumor efficacy of poly(D,L-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice.
    Gao L; Xia L; Zhang R; Duan D; Liu X; Xu J; Luo L
    Drug Des Devel Ther; 2017; 11():3065-3075. PubMed ID: 29118572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering.
    Wu L; Ding J
    Biomaterials; 2004 Dec; 25(27):5821-30. PubMed ID: 15172494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of soluble, salt-loaded, degradable PLGA films and their release of tetracycline.
    Webber WL; Lago F; Thanos C; Mathiowitz E
    J Biomed Mater Res; 1998 Jul; 41(1):18-29. PubMed ID: 9641620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo evaluation of a novel electrically conductive polypyrrole/poly(D,L-lactide) composite and polypyrrole-coated poly(D,L-lactide-co-glycolide) membranes.
    Wang Z; Roberge C; Dao LH; Wan Y; Shi G; Rouabhia M; Guidoin R; Zhang Z
    J Biomed Mater Res A; 2004 Jul; 70(1):28-38. PubMed ID: 15174106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.